EyeOnIPPatents, Trademarks, Trade Secrets, and Copyrights Oh My!
|Merck could extend Keytruda patent life with injectable|
|Key "Keytruda will begin to expire in 2028, opening the door to biosimilars...Merck is testing in clinical trials two versions of the drug that can be injected subcutaneously, a quick alternative to infusions."|
| 2022-12-02 06:28:01 |